Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase 1/2 4Phase NA 2Phase 2 2Phase 3 1

Status

Completed 80Recruiting 56Terminated 39Unknown 34Active not recruiting 19Not yet recruiting 6Withdrawn 4Suspended 4Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 13Other hematologic neoplasm 7Lymphoid 6Dermatologic 5Tumor-Agnostic 4Thoracic 4CNS 4Other solid neoplasm 3Myeloid 3Plasma cell 2Genitourinary 2Breast 2Sarcoma 1Gynecologic 1

Conditions

Neoplasms 4

Interventions

Maltose 1Fluorodeoxyglucose F18 1Flucytosine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Suspended × Tumor-Agnostic × Clear all
NCT02130492 2026-05-15

A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)

Weill Medical College of Cornell University

Phase 1/2 Suspended
30 enrolled
Tumor-Agnostic

Neoplasms

NCT06211933 2026-02-12

PULS

Centre Leon Berard

Phase 1/2 Suspended
26 enrolled
Tumor-Agnostic

Neoplasms

NCT06147505 2024-10-29

XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)

Dushu Lake Hospital Affiliated to Soochow University

Phase 1/2 Suspended
30 enrolled
Tumor-Agnostic

Neoplasms

NCT01562626 2021-05-12

Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors

Anaeropharma Science, Inc.

Phase 1/2 Suspended
75 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡